HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 2 filers reported holding HAEMONETICS CORP in Q1 2011. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,254 | -94.5% | 14 | -94.4% | 0.00% | – |
Q2 2020 | $23,000 | +35.3% | 252 | +44.0% | 0.00% | – |
Q1 2020 | $17,000 | +142.9% | 175 | +14.4% | 0.00% | – |
Q1 2016 | $7,000 | +16.7% | 153 | -18.6% | 0.00% | – |
Q4 2015 | $6,000 | +20.0% | 188 | +22.9% | 0.00% | – |
Q3 2015 | $5,000 | -16.7% | 153 | 0.0% | 0.00% | – |
Q2 2015 | $6,000 | -14.3% | 153 | 0.0% | 0.00% | – |
Q1 2015 | $7,000 | +133.3% | 153 | +104.0% | 0.00% | – |
Q4 2014 | $3,000 | -87.5% | 75 | -79.2% | 0.00% | -100.0% |
Q1 2011 | $24,000 | +4.3% | 360 | 0.0% | 0.00% | 0.0% |
Q4 2010 | $23,000 | +9.5% | 360 | 0.0% | 0.00% | 0.0% |
Q3 2010 | $21,000 | +10.5% | 360 | 0.0% | 0.00% | 0.0% |
Q2 2010 | $19,000 | -64.2% | 360 | -61.0% | 0.00% | -50.0% |
Q1 2010 | $53,000 | +3.9% | 922 | 0.0% | 0.00% | 0.0% |
Q4 2009 | $51,000 | -23.9% | 922 | -22.5% | 0.00% | -33.3% |
Q3 2009 | $67,000 | -1.5% | 1,190 | -0.7% | 0.00% | 0.0% |
Q2 2009 | $68,000 | -5.6% | 1,198 | -8.3% | 0.00% | -25.0% |
Q1 2009 | $72,000 | – | 1,306 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |